loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of DSSTox_CID_31467 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_31467

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,103Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Bilanoa

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 95

    2019 Revenue in Millions : 116

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 96

    2020 Revenue in Millions : 91

    Growth (%) : 14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 100

    2021 Revenue in Millions : 96

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 92

    2022 Revenue in Millions : 100

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Anti-allergic

    Currency : USD

    2017 Revenue in Millions : 19

    2016 Revenue in Millions : 21

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Anti-allergic

    Currency : USD

    2018 Revenue in Millions : 59

    2017 Revenue in Millions : 18

    Growth (%) : 230%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Bilanoa

    Bilastine

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Bilanoa

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Bilastine

    Main Therapeutic Indication : Immunology

    Currency : USD

    2019 Revenue in Millions : 113

    2018 Revenue in Millions : 61

    Growth (%) : 85

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF